Topotecan Weekly Versus Conventional 5-Day Schedule in Patients With Platinum-Resistant Ovarian Cancer: a randomized multicenter phase II trial of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group (Q33393033)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Topotecan Weekly Versus Conventional 5-Day Schedule in Patients With Platinum-Resistant Ovarian Cancer: a randomized multicenter phase II trial of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group |
scientific article |
Statements
1 reference
Topotecan Weekly Versus Conventional 5-Day Schedule in Patients With Platinum-Resistant Ovarian Cancer: a randomized multicenter phase II trial of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group (English)
1 reference
Dirk Stengel
1 reference
Philipp Harter
1 reference
Christian Kurzeder
1 reference
Antje Belau
1 reference
Thomas Bogenrieder
1 reference
Susanne Markmann
1 reference
Sven Mahner
1 reference
Lothar Mueller
1 reference
Ralf Lorenz
1 reference
Andreas Nugent
1 reference
Jochen Wilke
1 reference
Andreas Kuznik
1 reference
Gabriele Doering
1 reference
Arthur Wischnik
1 reference
Hans-Gerd Meerpohl
1 reference
Willibald Schroeder
1 reference
Werner Lichtenegger
1 reference
29 November 2010
1 reference
1 reference
Identifiers
1 reference